Literature DB >> 15131546

Long-term outcome of patients with vasovagal syncope.

Gonzalo Barón-Esquivias1, Francisco Errázquin, Alonso Pedrote, Aurelio Cayuela, Silvia Gómez, Almudena Aguilera, Ana Campos, Mónica Fernández, Juan I Valle, Mercedes Redondo, José M Fernández, Angel Martínez, José Burgos, Antoni Martínez-Rubio.   

Abstract

BACKGROUND: After abnormal head-up tilt test (HUT), several trials have evaluated treatment strategies for vasovagal syncope (VVS). However, few unequivocal results have been obtained. The aim of the study was to prospectively analyze the natural history of patients with VVS who did not undergo specific treatment but received education for avoiding syncope after an abnormal HUT.
METHODS: From 1996, 334 consecutive patients with VVS and an abnormal HUT result were followed. All of them received education for avoiding syncope as first-line therapy.
RESULTS: During 30.4 +/- 21 months, there were no cardiac deaths. However, 101 patients (30.2%) had recurrences (1 recurrence, n = 64; > or =2, n = 37), which were not influenced by the type of response during HUT or by age. Time to first recurrence was correlated with the number of recurrences (r: -0.34, P =.0001). Mean recurrence-free time was 50.1 months (95% CI 46-54) and the cumulative probability of no recurrence was 69.8%. Receiver operator character curve analysis, demonstrated significant differences in the recurrence rate between patients with <5 or > or =5 previous episodes of syncope (25.1% vs 44%; P =.001). In addition, the mean recurrence-free time of patients with <5 episodes was significantly longer (54.1 months) than in patients with > or =5 episodes (39.6 months; P =.0005). Multivariate logistic regression identified the previous number of episodes as an independent risk marker of recurrences (odds ratio 2.34, 95% CI 1.4-3.8, P =.001). Age (at HUT performance) as a continuous variable was not a predictor of outcome.
CONCLUSIONS: Survival of patients with VVS presenting after an abnormal HUT is excellent. Although the broad majority of those patients do not suffer recurrences after education, the number of previous syncopal episodes critically influences the recurrence rate.

Entities:  

Mesh:

Year:  2004        PMID: 15131546     DOI: 10.1016/j.ahj.2003.11.022

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Long-term follow-up of patients with syncope evaluated by head-up tilt test.

Authors:  Giulia Domenichini; Igor Diemberger; Mauro Biffi; Cristian Martignani; Cinzia Valzania; Matteo Bertini; Davide Saporito; Matteo Ziacchi; Angelo Branzi; Giuseppe Boriani
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

Review 2.  Renal nerve stimulation for treatment of neurocardiogenic syncope: a review from perspective of commercialization potential.

Authors:  B O'Brien; H Zafar; F Sharif
Journal:  Ir J Med Sci       Date:  2017-06-14       Impact factor: 1.568

3.  [A patient with syncope].

Authors:  Helene Höhler
Journal:  Med Klin (Munich)       Date:  2009-10-15

4.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

5.  A Case of Cardiac Arrest for 31 Seconds During Recovery After Intravenous Sedation.

Authors:  Kaoruko Hamazaki; Yasuhiko Kato; Akari Hasegawa; Hiroko Yoneda; Nahoka Miyatani; Yoshihiro Momota
Journal:  Anesth Prog       Date:  2019

6.  Gender difference in patients with recurrent neurally mediated syncope.

Authors:  Jungwae Park; Shin Yi Jang; Hye Ran Yim; Young Keun On; June Huh; Dae-Hee Shin; Jun Hyung Kim; June Soo Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

Review 7.  Current approach to the treatment of vasovagal syncope in adults.

Authors:  Tarek Hatoum; Satish Raj; Robert Stanley Sheldon
Journal:  Intern Emerg Med       Date:  2022-09-18       Impact factor: 5.472

8.  Comparison of recurrence rate based on the frequency of preceding symptoms in patients with neurocardiogenic syncope or presyncope.

Authors:  Seon Mee Lee; Hye Lim Oh; June Soo Kim; Jungwae Park; Hye Ran Yim; Dae Hee Shin; Young Keun On; Sang Hoon Lee
Journal:  Korean Circ J       Date:  2011-08-31       Impact factor: 3.243

9.  Positive result in the early passive phase of the tilt-table test: a predictor of neurocardiogenic syncope in young men.

Authors:  Jae-Sun Uhm; Ho-Joong Youn; Woo-Baek Chung; Yun-Seok Choi; Chul-Soo Park; Yong-Seog Oh; Wook-Sung Chung; Kyung-Il Park; Tae-Suk Kim
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

10.  Leadless pacing in a young patient with cardioinhibitory vasovagal syncope.

Authors:  Valentina De Regibus; Darragh Moran; Gian Battista Chierchia; Pedro Brugada; Carlo de Asmundis
Journal:  Indian Pacing Electrophysiol J       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.